...CRISPR systems. The CRISPR-Phage technology being developed by Locus Biosciences Inc....

...and lopinavir/ritonavir (see “Coronavirus Biology” ). Locus shares data on CRISPR-expressing phages for C. diff Locus Biosciences Inc....
...Cas3 KEAP1 - Kelch-like ECH-associated protein 1 NFE2L2 (NRF2) - Nuclear factor (erythroid-derived 2)-like 2 BioCentury Staff Locus Biosciences Inc. Harvard...

...system had editing efficiencies up to 50% in human cell lines. Another gene editing company, Locus Biosciences Inc....

...counterpart. In a paper published in Nature Biotechnology on Sept. 23, a team led by Locus Biosciences Inc....
...Francisella 1; HBE1 - Hemoglobin subunit ε1; IL-1RA (IL1RN) - Interleukin-1 receptor antagonist Lauren Martz, Associate Editor Locus Biosciences Inc. Duke...

...counterpart. In a paper published in Nature Biotechnology on Sept. 23, a team led by Locus Biosciences Inc....
...Francisella 1; HBE1 - Hemoglobin subunit ε1; IL-1RA (IL1RN) - Interleukin-1 receptor antagonist Lauren Martz, Associate Editor Locus Biosciences Inc. Duke...

...therapy in other disease areas with well established microbiome links, including metabolic and CNS diseases. Locus Biosciences Inc....
...for infectious disease and immune modulation Companies and Institutions Mentioned Eligo Bioscience S.A.S., Paris, France Locus Biosciences Inc....

...are targeting endogenous CRISPR machinery in bacterial pathogens, all of which raised money in 2017: Locus Biosciences Inc....

...parallel, Grøndahl said, with the first program expected to enter the clinic in two years. Locus Biosciences Inc....

...Janssen Pharmaceuticals Inc. partnered with Locus Biosciences Inc. (Morrisville, N.C.) to develop and commercialize CRISPR-Cas3-enhanced bacteriophage therapies against...
...Locus Biosciences Inc., Morrisville, N.C. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Business: Infectious Elizabeth S. Eaton Janssen Johnson & Johnson Locus Biosciences Inc. CRISPR-associated...

...using alternative CRISPR systems that employ CasX, CasY and ARMAN endonucleases to treat viral infections. Locus Biosciences Inc....
...BioTherapeutics Inc., Philadelphia, Pa. Intellia Therapeutics Inc. (NASDAQ:NTLA), Cambridge, Mass. Locana Inc., San Diego, Calif. Locus Biosciences Inc....